Lv1
90 积分 2022-07-13 加入
The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy
15天前
已完结
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Cell–drug conjugates
1个月前
已完结
Small-molecule RNA therapeutics to target prostate cancer
1个月前
已完结
Mechanisms of response and tolerance to active RAS inhibition in KRAS-mutant NSCLC
10个月前
已完结
Novel WRN Helicase Inhibitors Selectively Target Microsatellite Unstable Cancer Cells
1年前
已完结
Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma
1年前
已完结
GTP signaling links metabolism, DNA repair, and responses to genotoxic stress
1年前
已完结
Drugging RAS: Moving Beyond KRASG12C
1年前
已完结
皖公网安备34019202002308
